63 related articles for article (PubMed ID: 38523299)
1. The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review.
Matos AC; Marques IA; Pires AS; Valentim A; Abrantes AM; Botelho MF
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163815
[TBL] [Abstract][Full Text] [Related]
2. Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer.
Ding L; Jiang H; Li Q; Li Q; Zhang TT; Shang L; Xie B; Zhu Y; Ding K; Shi X; Zhu T; Zhu Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):90. PubMed ID: 38523299
[TBL] [Abstract][Full Text] [Related]
3. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.
Zhao L; Han S; Hou J; Shi W; Zhao Y; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16341-16352. PubMed ID: 34126594
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
7. HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer.
Liang Y; Wang Y; Zhang Y; Ye F; Luo D; Li Y; Jin Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Ma T; Kong X; Yang Q
Cell Death Dis; 2023 Jul; 14(7):434. PubMed ID: 37454220
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: Recent insights and therapies.
Zhou H; Tan L; Liu B; Guan XY
Biochem Pharmacol; 2023 Mar; 209():115441. PubMed ID: 36720355
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, Proliferation, and Autophagy Are Involved in Local Anesthetic-Induced Cytotoxicity of Human Breast Cancer Cells.
Chen JL; Liu ST; Huang SM; Wu ZF
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555096
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-κB signaling pathway.
Wang J; Liu X; Li P; Wang J; Shu Y; Zhong X; Gao Z; Yang J; Jiang Y; Zhou X; Yang G
J Biol Chem; 2022 Dec; 298(12):102630. PubMed ID: 36273585
[TBL] [Abstract][Full Text] [Related]
11. Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K/AKT pathway.
Qiao H; Zhang W; Liu P; Zhu R; Zhang J; Gao J; Li T; Zhang J
J Biochem Mol Toxicol; 2023 Jan; 37(1):e23233. PubMed ID: 36193553
[TBL] [Abstract][Full Text] [Related]
12. Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway.
Lu Y; Mao J; Xu Y; Pan H; Wang Y; Li W
Hum Exp Toxicol; 2022; 41():9603271221120652. PubMed ID: 36124980
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective.
Babu SPP; Venkatabalasubramanian S; Munisankar SR; Thiyagaraj A
Bull Cancer; 2022 Sep; 109(9):960-971. PubMed ID: 35853753
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
